Fernando Gerchman
Fernando Gerchman is a prominent member of the Scientific Department of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso) and serves as the coordinator for the working group responsible for developing new pharmacological guidelines for obesity treatment in Brazil. His recent work focuses on creating evidence-based recommendations for healthcare professionals regarding the use of medications like Ozempic, Mounjaro, and Wegovy, emphasizing the importance of individualized patient care and the need for ongoing treatment to manage obesity effectively.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Brazil | 1 | 7.00 | 0.07% | +0% | 211,049,527 | 141,739 | $1,500,000 | 1,007$ |
| Totals | 1 | 211,049,527 | 141,739 | $1,500,000 | 1,007$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Brazil:
Fernando Gerchman explains that the document is a guide based on evidence and the reality of the country.
7